ID: ALA5091982

Max Phase: Preclinical

Molecular Formula: C29H45BrO4

Molecular Weight: 537.58

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](O)[C@]2(C)[C@H](C)CC[C@]3(CC(=C)C(=O)[C@H]32)[C@@H](C)[C@@H]1OC(=O)CCCCCCCBr

Standard InChI:  InChI=1S/C29H45BrO4/c1-7-27(5)18-22(31)28(6)20(3)14-15-29(17-19(2)24(33)25(28)29)21(4)26(27)34-23(32)13-11-9-8-10-12-16-30/h7,20-22,25-26,31H,1-2,8-18H2,3-6H3/t20-,21+,22-,25+,26+,27-,28+,29+/m1/s1

Standard InChI Key:  FXQDMYFPCNIKTE-JRCAEBEASA-N

Associated Targets(Human)

Kasumi 1 420 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A-375 9258 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CT26 928 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

B16-F10 4610 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

4T1 1737 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 537.58Molecular Weight (Monoisotopic): 536.2501AlogP: 6.79#Rotatable Bonds: 9
Polar Surface Area: 63.60Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.89CX LogD: 6.89
Aromatic Rings: 0Heavy Atoms: 34QED Weighted: 0.12Np Likeness Score: 1.95

References

1. Zhang K, Song W, Wei M, Sun Y, Wang N, Ma L, Yu X, Gao R, Wang R, Zhang Y, Zheng N, Li N, Mu L, Tang Z, Li X, Yang C, Yang G..  (2021)  A Novel Anticancer Stem Cell Compound Derived from Pleuromutilin Induced Necroptosis of Melanoma Cells.,  64  (21.0): [PMID:34704758] [10.1021/acs.jmedchem.1c01123]

Source